Cargando…
Iron chelating properties of Eltrombopag: Investigating its role in thalassemia-induced osteoporosis
Chronic blood transfusions are responsible to cause iron overload, which leads to several complications to end organs and osteoporosis. Iron chelation is needed to remove iron excess and to contain bone-mass loss. Deferasirox is the most recent oral iron chelator that prevents transfusion related ir...
Autores principales: | Punzo, Francesca, Tortora, Chiara, Argenziano, Maura, Casale, Maddalena, Perrotta, Silverio, Rossi, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277068/ https://www.ncbi.nlm.nih.gov/pubmed/30507954 http://dx.doi.org/10.1371/journal.pone.0208102 |
Ejemplares similares
-
Eltrombopag and its iron chelating properties in pediatric acute myeloid leukemia
por: Argenziano, Maura, et al.
Publicado: (2021) -
CB2 Receptor Stimulation and Dexamethasone Restore the Anti-Inflammatory and Immune-Regulatory Properties of Mesenchymal Stromal Cells of Children with Immune Thrombocytopenia
por: Rossi, Francesca, et al.
Publicado: (2019) -
Emerging Roles of the Iron Chelators in Inflammation
por: Di Paola, Alessandra, et al.
Publicado: (2022) -
Eltrombopag in paediatric immune thrombocytopenia: Iron metabolism modulation in mesenchymal stromal cells
por: Di Paola, Alessandra, et al.
Publicado: (2021) -
The Endocannabinoid/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma
por: Rossi, Francesca, et al.
Publicado: (2019)